Sector News

GSK dodges UK strike with improved pay offer for staffers

May 29, 2022
Life sciences

GSK has averted an industrial kerfuffle in the United Kingdom.

A potential strike by more than 1,000 GSK engineers, technicians, laboratory analysts, warehouse workers and others has been called off after the employees—represented by Britain and Ireland’s biggest labor union Unite—accepted an improved pay offer from the British Big Pharma.

The staffers voted to strike last month after receiving a “derisory” pay raise offer of 2.75%, according to Unite. That sum was well below the U.K.’s rate of inflation, which clocked in at nine percent in late April, the labor union said at the time.

Now, following fresh negotiations, GSK has lifted its offer, Unite said Monday.

“We are pleased to have reached an agreement with our employees covered by collective bargaining agreements at UK manufacturing sites,” a GSK spokesperson said over email. “We are committed to maintaining positive relationships with our skilled manufacturing workforce and the unions that represent them.”

GSK said the updated offer consists of a 4.5% increase to base salary, which is backdated. Further, the deal includes a one-off special award to all GSK employees of one week’s pay, which is worth about 2% of base salary.

“Unite will be using this settlement as a stepping stone to ensure that in all future pay settlements GSK properly rewards its workforce,” Tony Devlin, Unite national officer, said in a statement in the union’s release.

There are about 700 GSK staffers in Unite, the company’s spokesperson told Fierce Pharma last month. About 500 members voted in last month’s strike bid, with 430 in favor of taking action. GSK has about 175 members in fellow U.K. trade union GMB, who did not vote for strike action, the company noted.

Last month, GSK provided a slightly different take on the potential strike. The company said it had offered a 4% increase to base salary—not the 2.75% bump reported by Unite—plus a one-off award worth about 2% of base salary. The company had also floated an annual bonus for 2021 that “paid out above-target,” the spokesperson explained via email.

GSK employs around 13,000 people in the U.K., some 3,500 of whom work at manufacturing sites, the spokesperson added.

By Fraiser Kansteiner


comments closed

Related News

March 25, 2023

UK regulator makes biggest changes in 20 years to speed up trials, attract global studies

Life sciences

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced several new measures to make it easier to run clinical trials in the country, marking the first time in 20 years the regulatory body has made such an overhaul.

March 25, 2023

Novo partners with Dewpoint to mine an emerging field for new drugs

Life sciences

Diabetes drugmaker Novo Nordisk is partnering with Dewpoint Therapeutics in a deal aimed at uncovering new treatments for insulin resistance by targeting cellular droplets known as biomolecular condensates. Dewpoint will receive $55 million upfront from Novo, which plans to develop small molecule drugs against targets discovered using Dewpoint’s technology.

March 25, 2023

Sanofi’s Dupixent receives EC approval for atopic dermatitis

Life sciences

Sanofi has secured approval for Dupixent (dupilumab) from the European Commission (EC) to treat severe atopic dermatitis in children aged six months to five years, who are systemic therapy candidates, in the European Union (EU). This approval makes Dupixent the first and only medicine available in the US and Europe for the treatment of such young children.

How can we help you?

We're easy to reach